1. Home
  2. EXPO vs SUPN Comparison

EXPO vs SUPN Comparison

Compare EXPO & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exponent Inc.

EXPO

Exponent Inc.

HOLD

Current Price

$65.83

Market Cap

3.0B

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$47.05

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPO
SUPN
Founded
1967
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.8B
IPO Year
1996
2010

Fundamental Metrics

Financial Performance
Metric
EXPO
SUPN
Price
$65.83
$47.05
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$88.00
$61.60
AVG Volume (30 Days)
490.5K
737.5K
Earning Date
04-30-2026
05-05-2026
Dividend Yield
1.87%
N/A
EPS Growth
N/A
N/A
EPS
0.59
N/A
Revenue
$582,014,000.00
$392,755,000.00
Revenue This Year
$12.75
$22.70
Revenue Next Year
$8.50
$19.14
P/E Ratio
$106.37
N/A
Revenue Growth
4.21
N/A
52 Week Low
$51.91
$32.83
52 Week High
$81.95
$59.68

Technical Indicators

Market Signals
Indicator
EXPO
SUPN
Relative Strength Index (RSI) 64.97 50.41
Support Level $64.48 $43.43
Resistance Level $69.49 $52.30
Average True Range (ATR) 1.91 1.62
MACD 0.14 -0.14
Stochastic Oscillator 98.66 24.38

Price Performance

Historical Comparison
EXPO
SUPN

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: